ADVFN ADVFN

Hot Features

Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
Avacta Group Plc

Avacta Group Plc (AVCT)

70.50
1.00
(1.44%)
終了 7月10日 12:30AM

Avacta Group Plc (AVCT) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
70.50
( 1.44% )
買値
69.00
売値
72.00
出来高
548,218
平均取引量 (3 か月)
2,143,264p
財務取引量
383,753p
69.00 日の範囲 71.00
31.50 52 週間の範囲 91.00
時価総額
企業価値
342.785M
前日終値
69.50
始値
70.00
最終取引時間
VWAP
70.00
歳入
113k
純利益
-38.61M
発行済株式数
454,966,407
浮動株比率 (%)
93.89%
機関投資家保有比率 (%)
76.94%
配当利回り
PER
-8.05
株価売上高倍率 (PSR)
3.03k
1 株当たり利益 (EPS)
-0.1
ベータ
-0.1

Avacta Group Plc について

Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally. The company’s lead product candidate is AVA6000, a peptide drug conjugate form of doxorubicin, which is an approved cancer drug with known severe ... Avacta Group Plc, together with its subsidiaries, engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally. The company’s lead product candidate is AVA6000, a peptide drug conjugate form of doxorubicin, which is an approved cancer drug with known severe toxicities. It also develops AVA6103, a peptide drug conjugate technology designed to deliver exatecan, a potent topoisomerase I inhibitor directly to tumors while limiting the exposure of the released exatecan in normal tissues; and AVA7100 that drives localization to fibroblast activation protein expressing tumors. The company was incorporated in 2003 and is headquartered in London, the United Kingdom. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
London, United Kingdom
設立
2026
Avacta Group Plc is listed in the Healthcare sector of the ロンドン証券取引所 with ticker AVCT. The last closing price for Avacta was 69.50p. Over the last year, Avacta shares have traded in a share price range of 31.50p to 91.00p.

Avacta currently has 454,966,407 shares in issue. The market capitalisation of Avacta is £320.75 million. Avacta has a price to earnings ratio (PE ratio) of -8.05.

AVCT 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-3-4.0816326530673.573.568.580108571.22912893DE
422.919708029268.580.568133335073.19877473DE
12-4-5.3691275167874.59167.45202738377.06795269DE
268.513.7096774194629149198236269.43089372DE
5239123.8095238131.59131.5246790864.29978878DE
156-35-33.1753554502105.5166.526215105965.36391916DE
260-81-53.4653465347151.5187.526201579782.17527323DE

AVCT - Frequently Asked Questions (FAQ)

What is the current Avacta Group Plc share price?
The current share price of Avacta Group Plc is 70.50p
How many Avacta Group Plc shares are in issue?
Avacta Group Plc has 454,966,407 shares in issue
What is the market cap of Avacta Group Plc?
The market capitalisation of Avacta Group Plc is GBP 320.75M
What is the 1 year trading range for Avacta Group Plc share price?
Avacta Group Plc has traded in the range of 31.50p to 91.00p during the past year
What is the PE ratio of Avacta Group Plc?
The price to earnings ratio of Avacta Group Plc is -8.05
What is the cash to sales ratio of Avacta Group Plc?
The cash to sales ratio of Avacta Group Plc is 3.03k
What is the registered address of Avacta Group Plc?
The registered address for Avacta Group Plc is Scale Space White City Imperial College Campus, London, Greater London, W12 7RZ
What is the Avacta Group Plc website address?
The website address for Avacta Group Plc is avacta.com
Which industry sector does Avacta Group Plc operate in?
Avacta Group Plc operates in the Biotechnology & Life Sciences sector

AVCT 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock